NCT06356376

Brief Summary

This study will assess changes in nerve excitability of C-fibers, and changes in sympathetic or parasympathetic tone, when the subject experiences pain and pain relief. The investigators will continuously measure blood pressure, heart rate, respiration rate, gastric motility, sympathetic skin response and C-fiber excitability while using thermal stimuli before and after an analgesic.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 17, 2023

Completed
3 days until next milestone

Study Start

First participant enrolled

December 20, 2023

Completed
4 months until next milestone

First Posted

Study publicly available on registry

April 10, 2024

Completed
20 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2024

Completed
Last Updated

April 10, 2024

Status Verified

December 1, 2023

Enrollment Period

4 months

First QC Date

December 17, 2023

Last Update Submit

April 9, 2024

Conditions

Keywords

PainExcitabilityMicroneurographyAutonomic nervous system

Outcome Measures

Primary Outcomes (1)

  • C-fiber excitability

    Changes in C-fiber excitability measured in latency changes after electrical stimulation with a paired pulse protocol compared to an unpaired electrical stimulus.

    Through study completion, an average of 6 months

Secondary Outcomes (5)

  • Action potential duration (ms)

    Through study completion, an average of 6 months

  • Action potential amplitude (V)

    Through study completion, an average of 6 months

  • Heart-rate variability (ms)

    Through study completion, an average of 6 months

  • Blood pressure variability (mmHg)

    Through study completion, an average of 6 months

  • Sympathetic Skin Response (V)

    Through study completion, an average of 6 months

Study Arms (1)

Healthy Participants

Device: Heat Stimulation

Interventions

Heat stimulation at a painful, but to the subject tolerable level.

Healthy Participants

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Healthy Subjects

You may qualify if:

  • Healthy Participants able to give informed consent.

You may not qualify if:

  • Chronic pain conditions
  • Neurological or Psychiatric disease
  • Other major diseases
  • Pain medication within the last 24 hours

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Danish Pain Research Center

Aarhus N, 8200, Denmark

RECRUITING

MeSH Terms

Conditions

AgnosiaPain

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Alexander G Kristensen, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 17, 2023

First Posted

April 10, 2024

Study Start

December 20, 2023

Primary Completion

April 30, 2024

Study Completion

April 30, 2024

Last Updated

April 10, 2024

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations